MEDICAL EXPENSES CONSULTING (UK) LIMITED

Company Registration Number:
02984598 (England and Wales)

Unaudited abridged accounts for the year ended 31 October 2024

Period of accounts

Start date: 01 November 2023

End date: 31 October 2024

MEDICAL EXPENSES CONSULTING (UK) LIMITED

Contents of the Financial Statements

for the Period Ended 31 October 2024

Balance sheet
Notes

MEDICAL EXPENSES CONSULTING (UK) LIMITED

Balance sheet

As at 31 October 2024


Notes

2024

2023


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 28,967 80,698
Investments:   0 0
Total fixed assets: 28,967 80,698
Current assets
Stocks: 0 0
Debtors: 4 1,535,674 959,722
Cash at bank and in hand: 197,662 350,994
Investments:   0 0
Total current assets: 1,733,336 1,310,716
Creditors: amounts falling due within one year: 5 (459,575) (352,964)
Net current assets (liabilities): 1,273,761 957,752
Total assets less current liabilities: 1,302,728 1,038,450
Creditors: amounts falling due after more than one year: 6 0 (42,500)
Provision for liabilities: (16,007) (20,374)
Total net assets (liabilities): 1,286,721 975,576
Capital and reserves
Called up share capital: 102 102
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0
Profit and loss account: 1,286,619 975,474
Shareholders funds: 1,286,721 975,576

The notes form part of these financial statements

MEDICAL EXPENSES CONSULTING (UK) LIMITED

Balance sheet statements

For the year ending 31 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 11 July 2025
and signed on behalf of the board by:

Name: MR I HOLMES
Status: Director

The notes form part of these financial statements

MEDICAL EXPENSES CONSULTING (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MEDICAL EXPENSES CONSULTING (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2024

2. Employees

2024 2023
Average number of employees during the period 10 5

MEDICAL EXPENSES CONSULTING (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2024

3. Tangible Assets

Total
Cost £
At 01 November 2023 230,153
Additions 4,676
Disposals (120,890)
Revaluations 0
Transfers 0
At 31 October 2024 113,939
Depreciation
At 01 November 2023 149,455
Charge for year 21,345
On disposals (85,828)
Other adjustments 0
At 31 October 2024 84,972
Net book value
At 31 October 2024 28,967
At 31 October 2023 80,698

MEDICAL EXPENSES CONSULTING (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2024

4. Debtors

Trade debtors falling due within one year - £378,802 (2023 - £22,025). Group debtors falling due within one year - £710,762 (2023 - £623,262). Other debtors falling due within one year - £446,110 (2023 - £314,435).

MEDICAL EXPENSES CONSULTING (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2024

5. Creditors: amounts falling due within one year note

Bank loans - £17,301 (2023 - £27,352), HP - £nil (2023 - £14,082), trade creditors - £6,854 (2023 - £10,130), group companies - £44,111 (2023 - £37,399), Taxation £232,592 (2023 - £130,780), other creditors £158,717 (2023 - £133,221).

MEDICAL EXPENSES CONSULTING (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2024

6. Creditors: amounts falling due after more than one year note

HP - £nil (2023 -£42,500)